Author(s)

Mamadou Badou Sanogo^1*, Aboubacar Sidiki Fofana², Atabième Kodio¹, Sidy Toure³, Magara Samake^2,4, Seydou Sy^1,5, Alkaya Toure¹, Hamadoun Yattara^1,5, Saharé Fongoro^1,5

¹Nephrology and Hemodialysis Department, The Point “G” University Hospital, Bamako, Mali.
²Nephrology Unit, The Fousseyni Daou Hospital, Kayes, Mali.
³Rheumatology Department, The Point “G” University Hospital, Bamako, Mali.
⁴National Center for Scientific and Technological Research, Bamako, Mali.
⁵Faculty of Medicine and Odontostomatology, The University of Science, Techniques and Technologies of Bamako, Bamako, Mali.

Introduction: Primary Sjögren’s syndrome (SS) is the most common connective tissue disease after rheumatoid arthritis and affects mostly women between 30 and 40 years of age with an estimated prevalence between 0.1% and 0.6%. This observation illustrates an incidental finding of a case of SS in a young female patient in a context of obstructive renal failure (ARF) due to uterine fibroids. Observation: This was a 31-year-old woman hospitalized for anuric AKI (Acute Kidney Injury) with a creatinine level of 1247 μmol/l. Her history included sickle cell disease A/C and an unoperated uterine fibroid diagnosed 3 years ago. Approximately 2 months before her admission, her symptomatology was made of dizziness, physical asthenia, vomiting, poly-arthralgia, morning rash, pollakiuria and oral dryness. Abdominal examination showed a painless transverse mass in the pelvis. Biological examination showed a CRP (C-reactive protein) level of 488 mg/l. The cytobacteriological examination of the urine was normal and the proteinuria was 1.35 g/24 hours. The CT scan showed kidneys measuring 110 mm on the right and 113 mm on the left associated with bilateral pyelo-caliceal dilatation on a large polymyomatous uterus of interstitial and submucosal type. Immunologically, the anti-nuclear factor, the rheumatoid factor and the anti-SSA antibodies were positive. The resumption of the interrogation within the framework of the research of the subjective dry syndrome to find a notion of intermittent xerophthalmia 4 months ago. The Schirmer test was positive in the left eye. The initial management consisted of a polymyomectomy after 3 sessions of hemodialysis. Background treatment combining prednisone 5 mg/day and methotrexate 20 mg/week was started in parallel with the use of artificial tears. The evolution after twelve (12) months of treatment was favorable with a complete disappearance of the signs dry syndrome and full recovery of renal function. Conclusion: SS can have an insidious evolution and remain stable for many years, hence its fortuitous discovery in this case of obstructive ARF on uterine fibroid. In this context we insist on the interest of the immunological assessment in a patient in period of genital activity with a significant proteinuria and non-specific extrarenal signs.

Obstructive Renal Failure, Fibroid, Sjögren’s Syndrome

Sanogo, M. , Fofana, A. , Kodio, A. , Toure, S. , Samake, M. , Sy, S. , Toure, A. , Yattara, H. and Fongoro, S. (2022) Sjögren’s Syndrome Revealed by Obstructive Renal Failure: A Case Report and Review of the Literature. Open Journal of Nephrology, 12, 375-381. doi: 10.4236/ojneph.2022.124038.